The Pharmacogenomics Market is estimated to be valued at US$14,028.01 million in 2023 and is expected to exhibit a CAGR of 11.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Pharmacogenomics is the study of how a person's genetic makeup affects their response to drugs. The aim of pharmacogenomics is to develop personalized medicine that is specifically ... Read more

Pharmacogenomics refers to a scientific approach used to study how genes affect individual responses to drug therapies. With the help of pharmacogenomics, researchers can develop targeted drugs and therapies customized according to an individual's unique genetic makeup and personal characteristics. Such customized drugs help optimize medical treatment through personalized medicines by determining the right dose for the right patient at the right time, thereby improving therapeutic efficacy ... Read more

The pharmacogenomics market involves the use of genomic information to guide prescription drug therapies. Pharmacogenomics is playing a key role in improving patient outcomes for treatment of various diseases like cancer, infectious diseases, neurological disorders and cardiovascular diseases. Molecular diagnostics are increasingly being adopted for genetic testing prior to prescribing drugs in order to avoid adverse drug reactions and determine optimal dosages based on a person's genetic ... Read more